Related Experiment Video
Updated: May 2, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance
Julia Hernandez-Rapp1, Séverine Martin-Lannerée2, Théo Z Hirsch2
1INSERM UMR-S1124 Paris, France ; Sorbonne Paris Cité, UMR-S1124, Université Paris Descartes Paris, France ; Université Paris Sud 11, ED419 Biosigne Orsay, France.
The cellular prion protein (PrP(c)) acts as a receptor for amyloid-beta (Aβ) peptides, potentially worsening neurotoxicity. Prion diseases impair Aβ clearance by hijacking PrP(c)-mediated signaling pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cellular prion protein (PrP(c)) is the normal form of the scrapie prion protein (PrP(Sc)), linked to transmissible spongiform encephalopathies.
- PrP(c) functions as a receptor for amyloid-beta (Aβ) peptides, mediating their neurotoxic effects.
- PrP(Sc) and Aβ can disrupt PrP(c)-dependent signaling pathways, contributing to disease pathogenesis.
Purpose of the Study:
- To summarize the link between PrP-mediated signaling and Aβ clearance.
- To discuss the pathological implications of this interaction.
Main Methods:
- Literature review and synthesis of existing research on PrP(c), Aβ, and neurodegenerative pathways.
- Analysis of studies investigating Aβ clearance mechanisms in prion-infected cells.
Main Results:
- PrP(c) acts as a crucial mediator in the neurotoxicity of Aβ.
- Prion infection leads to impaired Aβ clearance in neuronal cells.
- Disease-associated PrP(Sc) exploits PrP(c) signaling to initiate pathogenic events.
Conclusions:
- The interplay between PrP(c) and Aβ is complex and involves PrP(c)-mediated signaling.
- Dysregulation of Aβ clearance is a pathological consequence of prion infection, linked to PrP(c) signaling.
- Understanding this connection offers insights into neurodegenerative disease mechanisms.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer Disease ll: Pathophysiology
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization

